Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart

Molecular and Cellular Biochemistry

Volumn 343, Issue 1-2, 2010, Pages 75-81

  Yadav, Harlokesh Narayan ^a   Singh, Manjeet ^a   Sharma, P L ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Diabetes mellitus; Glycogen synthase kinase 3 ; Ischemic preconditioning; Mitochondrial permeability transition pore

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ATRACTYLOSIDE; CREATINE KINASE MB; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; HEPARIN; INDIRUBIN; LACTATE DEHYDROGENASE; LITHIUM CHLORIDE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HEART INFARCTION SIZE; HEART PROTECTION; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; ISOLATED HEART; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES;

ANIMALS; ATRACTYLOSIDE; BLOOD GLUCOSE; CREATINE KINASE, MB FORM; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; ISCHEMIC PRECONDITIONING; L-LACTATE DEHYDROGENASE; PHOSPHORYLATION; RATS; STREPTOZOCIN;

RATTUS;

EID: 77957595023     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0500-z     Document Type: Article

References (62)

1. CJ Murry AD Lopez 1997 Alternative projections of mortality and disability by cause 1990-2020 global burden of disease study Lancet 349 1498 1504
2. EJ Topol RM Calliff M Vandormael CL Grines BS George ML Sanz T Wall M O'Brien M Schwaiger FV Aguirre S Young JJ Pompa KN Sigman KL Lee SG Ellis 1992 The thrombolysis and angioplasty in myocardial infarction. A randomized trial of late reperfusion therapy for acute myocardial infarction Circulation 85 2090 2099 1591828
3. GF Baxter Z Ebrahim 2002 Role of bradykinin in preconditioning and protection of the ischaemic myocardium Br J Pharmacol 135 843 854 11861312
4. HM Piper Y Abdullah Schafer 2004 The first minutes of reperfusion: a window of opportunity for cardioprotection Cardiovasc Res 16 365 371
5. CE Murry JB Jennings KA Reimer 1986 Preconditioning with ischemia: a delay of lethal injury in ischemic myocardium Circulation 74 1124 1136 3769170
6. M Nakamura N Wang Z Zhao J Wilcox V Thourani R Guyton J Johansen 2000 Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart Cardiovasc Res 45 661 670 10728387
7. DJ Hausenloy MR Duchen DM Yellon 2003 Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury Cardiovasc Res 60 617 625 14659807
8. DV DeFily WM Chilian 1993 Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury Am J Physiol 265 H700 H706 8368371
9. JF Bouchard J Chouinard D Lamontagne 1998 Role of kinins in endothelial protective effect of ischemic preconditioning Br J Pharmacol 123 413 420 9504381 (Pubitemid 28059709)
10. RM Fryer PF Pratt AK Hsu GJ Gross 2001 Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection J Pharmacol Exp Ther 296 642 649 11160653
11. KE Iliodromitis A Lazou DT Kremastinos 2007 Ischemic preconditioning: protection against myocardial necrosis and apoptosis Vasc Health Risk Manag 3 629 637 18078014
12. P Ferdinandy Z Szilvassy GF Baxter 1998 Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon Trends Pharmacol Sci 19 223 229 9666713
13. P Ferdinandy 2003 Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia Br J Pharmacol 138 283 285 12540517 (Pubitemid 36188588)
14. P Abete N Ferrara A Cioppa P Ferrara S Bianco C Calabrese F Cacciatore G Longobardi F Rengo 1996 Preconditioning does not prevent postischemic dysfunction in aging heart J Am Coll Cardiol 27 1777 1786 8636568
15. P Liu B Xu TA Cavalieri CE Hock 2004 Attenuation of antioxidative capacity enhances reperfusion injury. In aged rat myocardium after MI/R Am J Physiol Heart Circ Physiol 287 H2719 H2727 15358609
16. L Snoeckx GJ van der Vusse WA Coumans P Willemsen P van der Nagpal RS Reneman 1986 Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischaemia Cardiovasc Res 20 67 75 2939955
17. LH Snoeckx GJ van der Vusse WA Coumans PH Willemsen RS Reneman 1993 Differences in ischaemia tolerance between hypertrophied hearts of adult and aged spontaneously hypertensive rats Cardiovasc Res 27 874 881 8348587
18. H Sasaki K Ogawa M Shimizu C Mori H Takatsuka F Okazaki M Kawai I Taniguchi S Mochizuki 2007 The insulin sensitizer pioglitazone improves the deterioration of ischemic preconditioning in type 2 diabetes mellitus rats Int Heart J 48 623 635 17998772
19. Z Giricz MM Lalu C Csonka P Bencsik R Shulz P Ferdinandy 2006 Hyperlipidaemia attenuate the infarct size-limitng effect of preconditioning: role of matrix metalloprotenase inhibition J Pharmacol ExpTher 316 154 161
20. I Ungi T Ungi Z Ruzsa E Nagy Z Zimmermann T Csont P Ferdinandy 2005 Hypercholesterolemia attenuate the anti-ischemic effect of preconditioning durining coronary angioplasty Chest 128 1623 1628 16162767
21. WB Kannel DL McGee 1979 Diabetes and cardiovascular risk factor: the Framingham study Circulation 59 8 13 758126
22. RD Abbott RP Donahue WB Kannel PW Wilson 1998 The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham study JAMA 260 3456 3460
23. J Herlitz GB Wognsen H Emanuelsson M Haglid T Karlsson P Albertsson S Westberg 1996 Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting Diabetes Care 19 698 703 8799622 (Pubitemid 126752470)
24. Y Liu JD Thornton MV Cohen JM Downey SW Schaffer 1993 Streptozotocin induced non insulin dependent diabetes protect the heart from infarction Circulation 88 1273 1278 8353889
25. T Tatsumi S Matoba M Kobara N Keira A Kawahara K Tsuruyuma T Tanaka M Katamura C Nakagawa B Ohta Y Yamahara J Asayama M Nakagawa 1998 Energy metabolism after ischemic preconditioning in streptozotocin induced diabetic rat hearts J Am Coll Cardiol 31 707 715 9502657
26. M Thirunavukkarasu S Varma KS Penumathsa B Juhasz L Zhan H Otani D Bagchi DK Das N Maulik 2007 Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase Free Radic Biol Med 43 720 729 17664136
27. A Tosaki DT Engelman RM Engelman DK Das 1996 The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts Cardiovasc Res 31 526 536 8689644
28. JR Kersten WG Toller ER Gross PS Pagel DC Warltier 2000 Diabetes abolishes ischemic preconditioning: role of glucose, insulin and osmolarity Am J Physiol Heart Circ Physiol 278 H1218 H1224 10749717
29. T Ravingerova R Stetka K Volkovova D Pancza A Dzurba A Ziegelhoffer J Styk 2000 Acute diabetes modulates response to ischemia in isolated rat heart Mol Cell Biochem 210 143 151 10976767
30. E Nieszner I Posa G Kocsis I Preda MZ Koltai 2002 Influence of diabetic state of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits Exp Clin Endocrinol Diabetes 110 212 218 12148084
31. HF Del Valle EC Lascano JA Negroni 2002 Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels Cardiovasc Res 55 642 659 12160962
32. HF Del Valle EC Lascano JA Negroni AJ Crottogini 2003 Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction Mol Cell Biochem 249 21 30 12956394
33. DR Hunter RA Haworth 1979 The Ca-induced membrane transition in mitochondria. The protective mechanisms Arch Biochem Biophys 195 453 459 383019
34. EJ Griffiths AP Halestrap 1995 Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion Biochem J 307 93 98 7717999
35. G Kroemer B Dallaporta M Resche-Rigon 1998 The mitochondrial death/life regulator in apoptosis and necrosis Annu Rev Physiol 60 619 642 9558479 (Pubitemid 28157889)
36. BW Doble JR Woodgett 2003 GSK-3: tricks of the trade for a multi-tasking kinase J Cell Sci 16 1175 1186
37. E Beurel RS Jope 2006 The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways Prog Neurobiol 79 173 189 16935409
38. DJ Hausenloy HL Maddock GF Baxter DM Yellon 2002 Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning Cardiovasc Res 55 534 543 12160950
39. M Juhaszaova DB Zorov SH Kim Pepe SFuQ KW Fishbein BD Ziman S Wang K Ytrehus CL Antos EN Olson SJ Sollott 2004 Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore J Clin Invest 113 1535 1549
40. J Feng E Lucchinetti P Ahuja T Pasch JC Perriard M Zaugg 2005 Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3 Anesthesiology 103 987 995 16249673
41. H Elder-Finkelman EG Krebs 1999 Increased glycogen synthase kinase-3 activity in diabetes- and obesity prone-C57BL/6J mice Diabetes 48 1662 1666
42. ER Gross AK Hsu GJ Gross 2004 Opioid-induced cardioprotection occurs via glycogensynthase kinase beta inhibition during reperfusion in intact rat hearts Circ Res 94 960 966 14976126
43. NJ Pearce JR Arch JC Clapham MP Coghlam SL Corcoran CA Lister A Llano GB Moore GJ Murphy SA Smith CM Taylor JW Yates AD Morrison AJ Harper L Roxbee-Cox A Abuin E Wargent HC Holder 2004 Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3 beta on a muscle-specific promoter Metabolism 53 1322 1330 15375789
44. ER Gross AK Hsu GJ Gross 2007 Diabetes abolished morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3β Diabetes 56 127 136 17192474
45. G Ozansoy FB Akin 2004 Effects of gemfibrozil treatment on vascular reactivity of streptozotocin- diabetic rat aorta J Pharma Pharmacol 56 241 246
46. P Trinder 1969 Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor Ann Clin Biochem 6 24
47. J Lott K Turner 1975 Evaluation of trinder's glucose oxidase method for measuring glucose in serum and urine Clin Chem 21 1754 1760 1237363
48. K Chopra M Singh N Kaul KJ Andrabi NK Ganguly 1992 Decrease of myocardial infarct size with dessferrioxamine. Possible role of oxygen free radicals in its ameliorative effect Mol Cell Biochem 113 71 76 1640938
49. V Parikh M Singh 1997 Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart J Cardiovasc Pharmacol 30 149 156 9269940
50. JA King 1959 A routine method for estimation of lactate dehydrogenase activity J Med Lab Tech 16 265 272
51. BP Hughes 1961 A method for the estimation of serum creatine kinase and aldose activity in the normal and pathological sera Clin Chim Acta 7 597 603
52. MC Fishbein S Meerbaum J Rit U Lando K Kanmatsuse JC Merair E Corday W Ganz 1981 Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique Am Heart J 101 593 600 6164281
53. SA Javadov S Clarke M Das EJ Griffiths KH Lim AP Halestrap 2003 Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart J Physiol 549 513 524 12692185
54. EJ Griffiths AP Halestrap 1993 Protection by cyclosporin A of ischemia reperfusion-induced damage in isolated rat hearts J Mol Cell Cardiol 25 1461 1469 7512654
55. Jinkum Xi H Wang A Robert A Mueller Edward Norfleet Zhelong Xu 2009 Mechanism of resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3β and mitochondrial permeability transition pore Eur J Pharmacol 604 111 116 19135050
56. SS Park H Zhao Y Jang RA Mueller Z Xu 2006 N6-(3-Iodobenzyl)-adenosine- 5′-N- methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3b J Pharmacol Exp Ther 318 124 131 16611852
57. DJ Hausenloy DM Yellon 2007 Preconditioning and postconditioning; united at reperfusion Pharmacol Therap 116 173 191
58. M Faghihi F Mirershadi AR Dehpour M Bazargan 2008 Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart Eur J Pharmacol 597 57 63 18789320
59. S Kaga L Zhan E Altaf N Maulik 2006 Glycogen synthase kinase-3β/β-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium J Mol Cell Cardiol 40 138 147 16288908
60. R Barillas I Friehs H Cao-Danh JF Martinez PJ del Nido 2007 Inhibition of glycogen synthase kinase-3β improves tolerance to ischemia in hypertrophied hearts Ann Throac Surg 84 126 133
61. M Desrois RJ Sidell D Gauguier LM King GK Radda K Clarke 2004 Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart Cardiovasc Res 61 288 296 14736545
62. B Huisamen 2003 Protein kinase B in the diabetic heart Mol Cell Biochem 249 31 38 12956395